- Home
- NKTR vs TSVT Comparison
NKTR vs TSVT Comparison
Compare NKTR & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- TSVT
- Stock Information
- Founded
- NKTR 1990
- TSVT 2021
- Country
- NKTR United States
- TSVT United States
- Employees
- NKTR N/A
- TSVT N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- NKTR Health Care
- TSVT Health Care
- Exchange
- NKTR Nasdaq
- TSVT Nasdaq
- Market Cap
- NKTR 238.7M
- TSVT 253.9M
- IPO Year
- NKTR 1994
- TSVT N/A
- Fundamental
- Price
- NKTR $1.32
- TSVT $4.83
- Analyst Decision
- NKTR Buy
- TSVT Buy
- Analyst Count
- NKTR 4
- TSVT 6
- Target Price
- NKTR $2.50
- TSVT $10.40
- AVG Volume (30 Days)
- NKTR 988.9K
- TSVT 344.9K
- Earning Date
- NKTR 11-05-2024
- TSVT 11-12-2024
- Dividend Yield
- NKTR N/A
- TSVT N/A
- EPS Growth
- NKTR N/A
- TSVT N/A
- EPS
- NKTR N/A
- TSVT N/A
- Revenue
- NKTR $93,157,000.00
- TSVT $44,120,000.00
- Revenue This Year
- NKTR N/A
- TSVT N/A
- Revenue Next Year
- NKTR N/A
- TSVT $22.42
- P/E Ratio
- NKTR N/A
- TSVT N/A
- Revenue Growth
- NKTR 6.17
- TSVT N/A
- 52 Week Low
- NKTR $0.41
- TSVT $1.54
- 52 Week High
- NKTR $1.93
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- NKTR 56.07
- TSVT 52.75
- Support Level
- NKTR $1.11
- TSVT $4.44
- Resistance Level
- NKTR $1.39
- TSVT $4.83
- Average True Range (ATR)
- NKTR 0.09
- TSVT 0.33
- MACD
- NKTR 0.01
- TSVT -0.00
- Stochastic Oscillator
- NKTR 75.00
- TSVT 56.86
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.